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Introduction
Parkinson disease (PD) is the second most 
prevalent neurodegenerative disorder, after 
Alzheimer disease (Lang and Lozano 1998). 
Exposure to metals has been implicated in 
the pathogenesis of PD. Manganese intoxica-
tion is recognized as a cause of parkinsonism 
at high levels of exposure (Guilarte 2010; 
Jankovic 2005). However, the pathology of 
manganese intoxication is distinct from that 
of PD (Jankovic 2005), and the causal asso-
ciation of exposure to manganese with PD 
continues to be debated (Fored et al. 2006; 
Fryzek et al. 2005; Mortimer et al. 2012). 
For example, a study that compared the food 
habits of 250 patients and 388 controls found 
that a high manganese intake combined with 
a high intake of iron was significantly associ-
ated with PD (Powers et al. 2003). In another 
study in Quebec, Canada, a slightly higher 
although not statistically significant risk of PD 
was observed among participants with occu-
pational exposure to manganese, iron, and 
aluminum (Zayed et al. 1990). At the same 
time, many studies of manganese and PD 
have been null (Hertzman et al. 1994; Seidler 
et al. 1996; Semchuk et al. 1993; Vieregge 
et al. 1995).
There has also been some evidence of 
onset of PD following occupational (Coon 
et al. 2006; Kuhn et al. 1998) as well as 
nonoccupational (Weisskopf et al. 2010) 
exposure to high levels of lead. Increased 
brain iron levels have been found in PD 
patients by some investigators, although 
this has not been confirmed in all studies 
(Logroscino et al. 1998, 2006, 2008). Some 
but not all studies have reported positive asso-
ciations between PD and exposure to copper 
(e.g., Gorell et al. 1997). Furthermore, 
mercury measured in blood, urine, and hair 
has been positively   associated with PD (Ngim 
and Devathasan 1989).
To our knowledge, to date only two 
epidemiologic studies have assessed exposure 
to airborne metals and PD in nonoccupa-
tional cohorts. A case–control study in 
Canada by Finkelstein and Jerrett (2007) 
reported a modest association between 
airborne manganese and PD. In a study of 
U.S. Medicare beneficiaries, Willis et al. 
(2010) used county-level data from the U.S. 
Environmental Protection Agency (EPA) 
Toxic Release Inventory (TRI) (U.S. EPA 
2010b) on copper, lead, and manganese and 
found significant associations between resi-
dence in urban counties with high levels of 
release of manganese and PD. 
In this study, we examined the associa-
tion between census tract–level air emissions 
of antimony, arsenic, cadmium, chromium, 
lead, manganese, mercury, and nickel, and 
risk of PD in a large prospective cohort of 
female nurses.
Methods
Study population. This study was conducted 
using data from the Nurses’ Health Study 
(NHS), an ongoing prospective cohort of 
female nurses initiated in 1976 and followed 
with biennial questionnaires collecting resi-
dential location and information on lifestyle 
factors and health outcomes. Residential loca-
tions were available throughout follow-up, 
which corresponds to exposure during adult-
hood in this cohort. At the initiation of the 
cohort in 1976, the 121,701 study partici-
pants were between 30 and 55 years of age and 
resided in 11 states (California, Connecticut, 
Florida, Maryland, Massachusetts, Michigan, 
New York, New Jersey, Pennsylvania, Ohio, 
and Texas). For each follow-up cycle, the rate 
of follow up has been > 90%. Information 
on state, county, and census tract of residence 
was derived from the residential address 
updated every 2 years. Detailed description 
of the cohort is provided elsewhere (Colditz 
et al. 1997). Data on airborne metal expo-
sures were available for 97,430 women at 
baseline in 1990.
PD ascertainment. A question regarding 
PD onset and diagnosis was first asked in 1994 
and has been asked every 2 years since. The 
ascertainment method for PD in this study has 
been described in detail previously (Ascherio 
et al. 2001). Briefly, each study participant 
who reports PD is sent a written request for 
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Background: Exposure to metals has been implicated in the pathogenesis of Parkinson 
disease (PD).
oBjectives: We sought to examine in a large prospective study of female nurses whether exposure 
to airborne metals was associated with risk of PD.
Methods: We linked the U.S. Environmental Protection Agency (EPA)’s Air Toxics tract-level 
data with the Nurses’ Health Study, a prospective cohort of female nurses. Over the course of 
18 years of follow-up from 1990 through 2008, we identified 425 incident cases of PD. We 
examined the association of risk of PD with the following metals that were part of the first 
U.S. EPA collections in 1990, 1996, and 1999: arsenic, antimony, cadmium, chromium, lead, 
manganese, mercury, and nickel. To estimate hazard ratios (HRs) and 95% CIs, we used the Cox 
proportional hazards model, adjusting for age, smoking, and population density.
results: In adjusted models, the HR for the highest compared with the lowest quartile of 
each metal ranged from 0.78 (95% CI: 0.59, 1.04) for chromium to 1.33 (95% CI: 0.98, 1.79) 
for mercury.
conclusions: Overall, we found limited evidence for the association between adulthood ambient 
exposure to metals and risk of PD. The results for mercury need to be confirmed in future studies.
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consent to contact her treating neurologist (or 
internist, if the neurologist is not available). 
Once consent is provided by the partici-
pant, the doctor is contacted for a copy of 
the medical record and asked to complete a 
questionnaire documenting the likelihood of 
the diagnosis of PD. The medical records are 
reviewed by a neurologist/movement disorder 
specialist (M.A.S.) who is blinded to the 
exposure status of the participant. We consid-
ered confirmed cases to be participants with 
medical record evidence of a final diagnosis 
of PD by a treating neurologist, or medical 
record evidence of at least two cardinal signs 
of PD (bradykinesia, rigidity, or rest tremor) 
in the absence of information suggesting an 
alternate diagnosis. Women who self-reported 
a PD diagnosis before 1990 or had evidence 
in their medical record indicating onset before 
1990 were excluded from the study.
Airborne metals exposure ascertainment. 
We used data on antimony, arsenic, cadmium, 
chromium, lead, manganese, mercury, 
and nickel exposure from the National Air 
Toxics Assessments (NATA) (U.S. EPA 
2011). NATA includes data on emissions of 
hazardous air pollutants (HAPs) from a variety 
of sources including major stationary sources 
(such as factories), other sources (such as dry 
cleaners, small manufacturers, and wildfires), 
and traffic sources (cars, boats). The U.S. 
EPA created this inventory by drawing on 
data from state and local air pollution inven-
tories and, if those were not available, on 
existing databases related to the U.S. EPA’s 
air toxics regulatory program, followed by the 
U.S. EPA TRI (U.S. EPA 2010b). NATA 
uses a complex dispersion model, ASPEN 
(Assessment System for Population Exposure 
Nationwide) (U.S. EPA 2010a), which esti-
mates annual average concentrations of the 
HAPs for each census tract in the contiguous 
United States and Puerto Rico. The model 
incorporates information about the rate, 
location, and height of release; meteorological 
factors; and pollutant-specific factors such as 
radioactive decay, deposition, and secondary 
formation. HAP data were downloaded from 
the U.S. EPA website on 23 June 2010, 
and additional archived data were received 
on compact disc from the U.S. EPA (2011). 
HAPs data from 1990, 1996, and 1999 were 
available. We linked the HAP data with the 
NHS, using U.S. census state, county and 
tract identifiers (U.S. Census Bureau 2010). 
We used updated metal exposure in our 
analyses: metal values measured in 1990 were 
assigned for cases with onset prior to 1996, 
metal measures in 1996 were assigned for cases 
with onset between 1996 and 2000, and metal 
measures in 1999 were assigned for cases with 
onset after 2000. We estimated associations 
between PD and the following metals avail-
able in all years: antimony, arsenic, cadmium, 
chromium, lead, manganese, mercury, and 
nickel. Although the U.S. EPA specifically 
advises against combining metal concentra-
tions measured at different time periods (U.S. 
EPA 2011), we performed a sensitivity analysis 
of associations with estimates of cumulative 
airborne metal exposures based on updated 
measurements at each time period, which 
is of interest because of the long preclinical 
phase of PD.
Statistical analyses. We used Cox propor-
tional hazards models adjusted for age in 
months (crude model), as well as a multi-
variable model adjusted additionally for 
smoking (one variable defined as never/past/
current and another continuous pack-years 
variable at baseline) and census tract–level 
population density (calculated as the number 
of people in the tract divided by the square 
miles of the tract, in quartiles) to calculate 
hazard ratios (HRs) for the association between 
exposure to airborne metals and risk of PD. 
We also conducted sensitivity analyses further 
adjusting for tract-level income (quartiles). 
Person-years of follow-up were calculated from 
baseline in 1990, through the end of follow-up 
(30 June 2008), death, or date of PD onset, 
whichever occurred earlier. The relationship 
between PD onset and metals exposure was 
examined for each metal individually, coded in 
quartiles (using cutoffs based on the exposure 
distribution over the entire study period), 
or continuously in separate models. Because 
smoking has been established as protective 
against PD based in multiple epidemiologic 
studies (Hernán et al. 2001), we performed 
additional analyses stratified by smoking status 
at baseline (ever vs. never smoker) and tested 
for interaction between each of the metals and 
smoking, by using the likelihood ratio test 
to compare a model that included a product 
term between smoking (ever/never) and the 
metal coded as an ordinal variable to a model 
without such a term. We also conducted addi-
tional analyses stratified by population density 
in 1990—the time of the metal exposure 
assessment—to examine the potential interac-
tion of rural versus urban living with the effects 
of airborne metals. In these analyses, women 
residing in counties with ≥ 250,000 inhabit-
ants were considered urban dwellers, whereas 
those in counties with < 250,000 inhabitants 
were considered rural dwellers.
All analyses were performed using SAS 
version 9.1 (SAS Institute Inc., Cary, NC). 
All analyses were conducted at the 0.05 alpha 
level, and all tests were two-sided. p-Values 
for trend test were based on a linear model 
through the quartile medians. All members of 
the NHS provide informed consent, implied 
through the return of the questionnaires. 
The study was approved by the institutional 
review of Brigham and Women’s Hospital. 
Results
Between the study baseline in 1990 and the 
end of the study in 2008, we confirmed 425 
cases of PD with data available on metal expo-
sures. Table 1 shows the baseline characteris-
tics of the study participants. Age, body mass 
index (BMI), and smoking did not differ with 
quartile of total metal exposure (constructed 
as the sum of all metals in the study). 
Participants residing in census tracts with the 
lowest quartile of metal exposure also lived in 
tracts with the lowest median family income 
and lowest population density. Metal expo-
sures were highly intercorrelated (Table 2), 
with Spearman correlation   coefficients ranging 
from 0.38 to 0.68.
Metals exposures were not significantly 
associated with PD (Table 3) in age-adjusted 
Table 1. Age-standardized characteristics at study baseline in 1990 of the 97,430 female NHS participants 
by quartile of total metal exposure (mean ± SD or percentage). 
Characteristic Quartile 1 Quartile 2 Quartile 3 Quartile 4
Age (years) 57.8 ± 7.2 57.6 ± 7.2 57.7 ± 7.1 58.0 ± 7.1
Pack-years smoking 11.8 ± 18.1 12.4 ± 18.5 12.0 ± 18.4 11.3 ± 18.0
BMI 25.9 ± 4.9 25.8 ± 4.9 25.9 ± 4.9 25.9 ± 5.0
Never-smoker (%) 45 42 43 44
Median tract household income, 1990 55,211 ± 9,501 66,534 ± 25,586 68,866 ± 27,274 66,096 ± 27,507
Median tract population density, 1990 
(average persons/square mile)
1,450 ± 3,840 2,783 ± 4,458 4,010 ± 6,770 8,008 ± 15,744
Urban dwelling (% living in county with 
≥ 250,000 inhabitants)
30 70 80 80
Table 2. Spearman correlations between the metals examined in this study.
Metal Antimony Arsenic Cadmium Chromium Lead Manganese Mercury Nickel
Antimony 1.00 0.57 0.52 0.38 0.54 0.54 0.50 0.60
Arsenic 1.00 0.68 0.54 0.66 0.61 0.61 0.62
Cadmium 1.00 0.51 0.64 0.59 0.66 0.58
Chromium 1.00 0.55 0.50 0.44 0.55
Lead 1.00 0.65 0.57 0.57
Manganese 1.00 0.47 0.52
Mercury 1.00 0.58
Nickel 1.00Airborne metals and Parkinson disease
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or multivariable (age, smoking, and popu-
lation density)–adjusted models. In the 
main analyses, there was a suggestion of a 
positive monotonic association with exposure 
to mercury [the HR comparing to the top 
quartile of mercury exposure with the bottom 
quartile was 1.33 (95% CI: 0.98, 1.79; 
ptrend = 0.10)].
Because at the census tract level total 
metal exposure was correlated with income 
(Table 1), we conducted additional sensitivity 
analyses adjusted for income. This adjustment 
did not substantially influence the results 
(data not shown). The results of sensitivity 
analyses that used cumulative updating were 
not significantly different from our primary 
analysis: Mercury was still the only metal 
that gave a suggestion of an association with 
PD risk (ptrend = 0.14) in these analyses (data 
not shown).
In analyses stratified by smoking 
(Table 4), we did not observe that smoking 
had any statistically significant effect modi-
fication of associations with any of the 
metals. Among never-smokers, we observed a 
significant increasing risk of PD with higher 
mercury exposure (HR comparing top with 
bottom quartile: 1.68; 95% CI: 1.11, 1.25; 
ptrend = 0.04) but not among ever-smokers 
(HR:0.99; 95% CI: 0.63, 1.55; p-trend 
= 0.85); the p-value for interaction with 
smoking was not significant (pinteraction = 
0.29). We did not observe evidence of interac-
tions between smoking and any of the other 
metals in the study.
In analyses stratified by population 
density (Table 5), we observed a marginally 
significant interaction for arsenic (pinteraction = 
0.06) consistent with evidence of a negative 
association among those living in less densely 
populated counties versus a weak positive asso-
ciation in highly populated counties. For most 
of the metals in the study, the relative risks 
among participants living in urban counties 
were higher than among those living in rural 
counties, although none of the other inter-
action tests were significant. The relative risk 
was particularly high for mercury exposure 
among those living in urban counties (HR 
comparing top quartile of exposure with 
bottom quartile was 1.84 (95% CI: 1.13, 
2.99; ptrend = 0.14), although risk was also 
elevated in the low population density 
group (HR: 1.32; 95% CI: 0.79, 1.29) and 
the p-value did not indicate an interaction 
(pinteraction = 0.86).
Discussion
In this prospective cohort study of female 
nurses, we did not observe a statistically 
significant association between U.S. EPA 
HAP-modeled concentrations overall 
and risk of PD. In adjusted models, the 
HR for the highest compared with the 
lowest quartiles of each metal ranged from 
0.78 (95% CI: 0.59, 1.04) for chromium 
to 1.33 (95% CI: 0.98, 1.79) for mercury. 
The association with mercury was stronger 
in nonsmokers as well as among participants 
living in urban counties.
To our knowledge, to date only two 
studies have addressed ambient air pollu-
tion and risk of PD. In Hamilton, Ontario, 
Canada, in a case–control study designed 
to examine the association between traffic 
pollution in general and PD, Finkelstein and 
Jerrett (2007) observed a modest increase in 
risk of PD among individuals with higher 
exposure to airborne manganese. However, 
this study identified cases using prescrip-
tion data from a drug registry or a physician 
diagnosis code from the Ontario Health 
Insurance Plan, resulting in potential inclu-
sion of subjects with manganism and not true 
PD, and thus potentially augmenting the 
association seen for manganese. In contrast, 
our study relied on PD cases confirmed 
through neurologist medical record review.
In one study, Willis et al. (2010) used 
physician disease codes to identify over 35,000 
incident PD cases in a database of 29 million 
Medicare beneficiaries of PD, and compared 
the risk of PD among participants living in 
urban counties with high versus low cumula-
tive industrial release of copper, manganese, 
or lead based on GIS-derived estimates from 
the U.S. EPA TRI (U.S. EPA 2010b). A major 
advantage of that study was its large sample 
size. Willis et al. (2010) found that partici-
pants residing in counties with the highest 
25% of manganese release had an almost 80% 
higher risk of PD compared with those living 
in the counties with the lowest 25% for lead, 
copper, and manganese release. However, 
this study relied only on direct emissions data 
from the U.S. EPA TRI as their exposure. As 
Table 3. Exposure to individual metal HAPsa and risk of PD among participants on the NHS (n = 97,430) 






c Age adjusted Fully adjustedb
Antimony
Q1 0.000034 46,3350 113 1.00 (Referent) 1.00 (Referent)
Q2 0.000138 45,0715 104 0.97 (0.74, 1.27) 0.98 (0.75, 1.28)
Q3 0.000287 44,4776 104 1.00 (0.76, 1.30) 1.01 (0.77, 1.33)
Q4 0.000682 42,6213 104 1.01 (0.77, 1.32) 1.04 (0.78, 1.38) 0.70
Arsenic
Q1 0.000073 45,7965 117 1.00 (Referent) 1.00 (Referent)
Q2 0.000173 49,4663 94 0.84 (0.64, 1.10) 0.86 (0.65, 1.13)
Q3 0.000293 44,7912 112 1.01 (0.78, 1.30) 1.03 (0.78, 1.37)
Q4 0.000610 42,4514 102 0.94 (0.72, 1.23) 0.95 (0.71, 1.27) 0.95
Cadmium
Q1 0.000025 44,3659 120 1.00 (Referent) 1.00 (Referent)
Q2 0.000097 44,2193 95 1.06 (0.82, 1.38) 1.08 (0.83, 1.42)
Q3 0.000204 44,8139 116 1.02 (0.78, 1.32) 1.04 (0.79, 1.38)
Q4 0.000474 45,1063 94 0.90 (0.68, 1.19) 0.90 (0.67, 1.22) 0.26
Chromium
Q1 0.000165 44,3659 120 1.00 (Referent) 1.00 (Referent)
Q2 0.000478 44,2193 95 0.86 (0.67, 1.10) 0.86 (0.67, 1.11)
Q3 0.000926 44,8139 116 1.05 (0.83, 1.33) 1.05 (0.82, 1.34)
Q4 0.001961 45,1063 94 0.80 (0.61, 1.03) 0.78 (0.59, 1.04) 0.11
Lead
Q1 0.001971 45,9922 117 1.00 (Referent) 1.00 (Referent)
Q2 0.002896 45,2125 100 0.91 (0.70, 1.19) 0.92 (0.70, 1.22)
Q3 0.004890 44,2968 108 0.99 (0.76, 1.28) 0.99 (0.75, 1.31)
Q4 0.010354 43,0039 100 0.91 (0.70, 1.19) 0.90 (0.67, 1.22) 0.54
Manganese
Q1 0.001109 45,9870 101 1.00 (Referent) 1.00 (Referent)
Q2 0.002488 45,7074 128 1.30 (1.00, 1.68) 1.30 (1.00, 1.70)
Q3 0.004118 44,2783 96 0.99 (0.75, 1.32) 1.01 (0.75, 1.35)
Q4 0.007797 42,5327 100 1.05 (0.79, 1.38) 1.04 (0.77, 1.40) 0.58
Mercury
Q1 0.001543 44,9057 96 1.00 (Referent) 1.00 (Referent)
Q2 0.001649 45,4765 106 1.14 (0.87, 1.50) 1.15 (0.87, 1.52)
Q3 0.001867 45,7804 111 1.20 (0.92, 1.58) 1.24 (0.93, 1.65)
Q4 0.002405 42,3428 112 1.28 (0.97, 1.68) 1.33 (0.99, 1.79) 0.10
Nickel
Q1 0.000873 45,6523 109 1.00 (Referent) 1.00 (Referent)
Q2 0.002485 44,8290 118 1.15 (0.88, 1.48) 1.02 (0.76, 1.34)
Q3 0.004934 45,1511 107 1.02 (0.78, 1.33) 0.91 (0.67, 1.24)
Q4 0.011718 42,8731 91 0.91 (0.68, 1.20) 1.01 (0.79, 1.24) 0.25
aHAP metal levels were obtained from the U.S. EPA (2011). We used updated metal exposure incorporating all years of 
HAP measurement in our analyses. bAdjusted for age and smoking (never, past, current, and pack-years) and population 
density (quartiles). cBased on linear model through the quartile medians.Palacios et al.
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discussed in “Methods,” the U.S. EPA TRI 
data contribute to the NATA HAPs data 
used in our study; however, the NATA data 
are also supplemented by data from local air 
pollution inventories and other U.S. EPA air 
toxics databases (U.S. EPA 2011). The TRI are 
raw emissions data, whereas the NATA data 
used in our study (U.S. EPA 2011) include 
a dispersion model that accounts for disper-
sion of air pollution, including across tract and 
county lines. Thus, the NATA data should 
provide a more accurate measure of exposure 
to airborne metals than the TRI data. Also, 
the smallest geographic unit in the study by 
Willis et al. (2010) was county, whereas we 
were able to estimate pollution concentration 
estimates at the census tract level. In contrast 
to Willis et al., we did not observe an asso-
ciation between higher exposure to airborne 
manganese and risk of PD. Our primary 
analyses were not restricted to urban or rural 
areas, but we conducted additional analyses 
stratified by low versus high population density 
(dichotomized in the same way as by Willis 
et al., where counties with ≥ 250,000 inhabit-
ants were considered urban). In our study, for 
most metals the observed HRs associated with 
metal exposure were higher in the high popula-
tion–density strata than in the low popula-
tion–density strata, although except for arsenic, 
for which we observed a marginally significant 
pinteraction of 0.06, none of the other tests for 
interaction were significant. Also, our study 
included only women, and all the participants 
were nurses. We cannot, therefore, exclude 
the possibility that our results would have 
been different had our study focused on men 
or on individuals occupationally exposed to 
pesticides or other chemicals. An inter  action 
between manganese-containing fungicides 
and paraquat, for example, has been reported 
in animal models of PD (Thiruchelvam et al. 
2000). Likewise, in humans, simultaneous 
exposure to maneb and paraquat in partici-
pants ≤ 60 years old was associated with a 4.17 
odds of PD, whereas exposure to either pesti-
cide alone was associated with a 2.27 odds of 
PD (Costello et al. 2009).
The association between exposure to 
mercury and PD in the present study is 
supported by some (Ngim and Devathasan 
1989; Seidler et al. 1996) but not all (Semchuk 
et al. 1993; Wechsler et al. 1991) prior studies. 
The association with mercury was stronger 
among never-smokers and residents of urban 
counties (with ≥ 250,000 inhabitants). 
Mercury is a heavy metal, and could contribute 
to oxidative damage in the substantia nigra; 
however, other heavy metals, such as iron 
(Lezak 1995), could also have this effect, so it 
is unclear why we saw an association with PD 
with mercury but not other heavy metals in 
this study.
Table 4. Exposure to individual metal HAPsa and risk of PD among participants on the NHS (n = 97,430) follow-up, 1990–2008, by quartile (Q) of each metal 
exposure stratified by smoking status.
Metal HAP
Never-smoker Ever-smoker
pinteraction Person-years Cases HR (95% CI)b ptrend
c Person years Cases HR (95% CI)b ptrend
c
Antimony
Q1 205,420 60 1.00 (Referent) 249,179 53 1.00 (Referent)
Q2 198,308 61 1.06 (0.74, 1.52) 241,434 43 0.88 (0.59, 1.33)
Q3 193,544 51 0.90 (0.61, 1.32) 236,848 53 1.15 (0.78, 1.71)
Q4 184,744 55 0.99 (0.67, 1.47) 0.95 217,866 48 1.10 (0.73, 1.67) 0.48 0.58
Arsenic
Q1 210,463 63 1.00 (Referent) 237,236 48 1.00 (Referent)
Q2 194,833 48 0.83 (0.56, 1.23) 245,601 42 0.88 (0.58, 1.32)
Q3 186,002 60 1.08 (0.73, 1.59) 244,303 42 0.94 (0.61, 1.43)
Q4 190,718 56 0.96 (0.64, 1.43) 0.94 218,188 51 0.92 (0.59, 1.42) 0.90 0.97
Cadmium
Q1 209,521 60 1.00 (Referent) 234,166 51 1.00 (Referent)
Q2 957,711 59 1.06 (0.73, 1.54) 244,381 54 1.08 (0.73, 1.62)
Q3 185,869 53 0.99 (0.66, 1.48) 251,031 54 1.04 (0.68, 1.59)
Q4 190,854 55 0.97 (0.66, 1.46) 0.84 215,750 38 0.80 (0.50, 1.27) 0.18 0.46
Chromium
Q1 202,837 65 1.00 (Referent) 229,154 55 1.00 (Referent)
Q2 189,959 50 0.86 (0.61, 1.23) 238,065 44 0.82 (0.56, 1.19)
Q3 190,332 61 1.10 (0.78, 1.55) 242,816 55 0.97 (0.66, 1.40)
Q4 198,888 51 0.81 (0.55, 1.20) 0.33 235,293 43 0.74 (0.49, 1.13) 0.24 0.92
Lead
Q1 208,472 64 1.00 (Referent) 239,836 53 1.00 (Referent)
Q2 190,940 47 0.81 (0.55, 1.20) 248,120 53 1.02 (0.68, 1.54)
Q3 189,998 61 1.01 (0.69, 1.50) 238,962 46 0.92 (0.59, 1.42)
Q4 192,605 55 0.81 (0.54, 1.20) 0.90 218,411 45 0.92 (0.58, 1.44) 0.63 0.86
Manganese
Q1 198,449 52 1.00 (Referent) 252,400 49 1.00 (Referent)
Q2 197,675 73 1.37 (0.95, 1.96) 247,611 54 1.19 (0.80, 1.77)
Q3 192,392 51 0.96 (0.64, 1.44) 232,493 45 1.08 (0.71, 1.65)
Q4 193,500 51 0.92 (0.61, 1.40) 0.98 212,824 49 1.20 (0.78, 1.84) 0.37 0.49
Mercury
Q1 206,460 47 1.00 (Referent) 217,568 49 1.00 (Referent)
Q2 199,558 63 1.46 (0.99, 2.16) 245,796 43 0.84 (0.56, 1.29)
Q3 191,627 52 1.30 (0.85, 1.98) 255,953 58 1.10 (0.73, 1.67)
Q4 184,371 65 1.68 (1.11, 2.55) 0.04 226,011 47 0.99 (0.63, 1.55) 0.85 0.29
Nickel
Q1 211,260 57 1.00 (Referent) 234,868 52 1.00 (Referent)
Q2 195,949 63 1.21 (0.83, 1.76) 239,515 55 1.09 (0.74, 1.63)
Q3 191,980 59 1.13 (0.76, 1.68) 245,360 48 0.91 (0.59, 1.40)
Q4 182,828 48 0.96 (0.62, 1.47) 0.46 225,585 42 0.86 (0.55, 1.35) 0.36 0.90
aHAP metal levels were obtained from the U.S. EPA (2011). We used updated metal exposure incorporating all years of HAP measurement in our analyses. bAdjusted for age and popu-
lation density (quartiles). cBased on linear model through the quartile medians.Airborne metals and Parkinson disease
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One limitation of our work is that 
the levels of airborne metals were not 
measured directly, but rather were based on 
linkage with the U.S. EPA HAP-modeled 
concentrations. The use of census tract–level 
modeled estimates of air pollution may have 
obscured a true association between airborne 
metals and PD. Additionally, PD is thought 
to have a long preclinical period, so the 
ideal measure of exposure would have been 
a cumulative lifetime exposure to airborne 
metals. However, only HAPSs measures in 
1990, 1996, and 1999 were available, and 
according to the U.S. EPA (2011), it was not 
advisable to combine the data into cumulative 
analyses. Thus, in our primary analyses we 
used exposure from only one time point for 
each PD case, as appropriate. This could have 
potentially biased our results. However, we 
did conduct analyses combining the three 
separate metals assessments into a cumulative 
measure, and confirmed that these results 
did not differ from the results of our primary 
analyses (data not shown). Also, it is not 
known how much time the participants spent 
inside versus outside their homes, and the 
HAP data set is a measure of outdoor expo-
sures only. Penetration of outdoor pollut-
ants indoors is possible, but depends on the 
  ventilation rates of the individual dwellings.
The strengths of this study include its 
large size and a long, prospective follow-
up, which included a large number of PD 
cases confirmed through neurologist medical 
record review. The study area included the 
whole contiguous United States, allowing 
for a wide range of exposure values for 
the airborne metals of interest. Among 
the limitations, our study included only 
women who were unlikely to be occupa-
tionally exposed to metals, pesticides, or 
other toxicants that might interact with 
metals. However, this aspect of our study is 
also an advantage because this is one of the 
few studies of airborne metal exposure in a 
 nonoccupational  cohort.
Conclusion
Overall, we found little evidence that airborne 
metal exposures were associated with PD in 
this large prospective cohort of female nurses. 
There was limited evidence of an association 
between mercury exposure and PD, particu-
larly among never-smokers and among 
participants living in counties with popula-
tions ≥ 250,000 persons. The results suggest 
that exposure to airborne metals is by itself 
unlikely to be a major cause of PD among 
U.S. women without occupational exposures 
to metals. The lack of association with most 
metals in this study as well the observed asso-
ciation with mercury needs to be confirmed in 
future studies.
Table 5. Exposure to individual metal HAPsa and risk of PD among participants on the NHS (n = 97,430) follow-up, 1990–2008, by quartile (Q) of each metal 
exposure stratified by county-level population density low (< 250,000 persons per county) vs. high (≥ 250,000 persons per county). 
Metal HAP
Low population density High population density
Person-years Cases HR (95% CI)b ptrend
c Person-years Cases HR (95% CI)b ptrend
c pinteraction
Antimony
Q1 256,829 68 1.00 (Referent) 206,521 45 1.00 (Referent)
Q2 179,049 61 1.13 (0.79, 1.64) 271,666 53 0.92 (0.62, 1.37)
Q3 113,333 26 0.93 (0.59, 1.48) 331,443 78 1.10 (0.76, 1.58)
Q4 64,700 14 0.88 (0.49, 1.59) 0.19 361,513 90 1.10 (0.77, 1.60) 0.35 0.21
Arsenic
Q1 307,615 90 1.00 (Referent) 150,351 27 1.00 (Referent)
Q2 150,741 35 0.84 (0.56, 1.26) 303,922 59 1.06 (0.67, 1.68)
Q3 80,920 20 0.91 (0.55, 1.51) 366,992 92 1.33 (0.85, 2.07)
Q4 74,637 14 0.65 (0.36, 1.15) 0.15 349,877 88 1.28 (0.81, 2.01) 0.37 0.06
Cadmium
Q1 305,054 84 1.00 (Referent) 149,459 27 1.00 (Referent)
Q2 154,477 42 1.08 (0.74, 1.59) 298,153 71 1.27 (0.81, 1.99)
Q3 75,229 15 0.81 (0.46, 1.42) 377,375 93 1.26 (0.81, 1.96)
Q4 79,151 18 0.86 (0.51, 1.45) 0.45 346,155 75 1.03 (0.65, 1.64) 0.43 0.60
Chromium
Q1 298,746 86 1.00 (Referent) 144,913 34 1.00 (Referent)
Q2 161,051 38 0.87 (0.60, 1.27) 281,142 57 0.92 (0.64, 1.32)
Q3 84,838 23 0.99 (0.63, 1.55) 363,301 93 1.15 (0.82, 1.61)
Q4 69,277 12 0.63 (0.34, 1.17) 0.19 381,786 82 0.88 (0.61, 1.27) 0.35 0.31
Lead
Q1 319,326 90 1.00 (Referent) 140,596 27 1.00 (Referent)
Q2 148,960 38 1.02 (0.69, 1.50) 303,166 62 0.99 (0.62, 1.57)
Q3 92,101 21 0.90 (0.55, 1.47) 350,867 87 1.15 (0.73, 1.80)
Q4 53,525 10 0.71 (0.36, 1.38) 0.26 376,514 90 1.04 (0.65, 1.65) 0.84 0.17
Manganese
Q1 266,167 64 1.00 (Referent) 193,703 37 1.00 (Referent)
Q2 161,175 50 1.32 (0.90, 1.91) 295,899 78 1.36 (0.91, 2.02)
Q3 101,067 24 1.02 (0.63, 1.64) 341,716 72 1.05 (0.70, 1.58)
Q4 85,503 21 1.02 (0.61, 1.69) 0.61 339,824 79 1.08 (0.72, 1.63) 0.70 0.91
Mercury
Q1 285,651 75 1.00 (Referent) 163,406 21 1.00 (Referent)
Q2 174,527 41 0.99 (0.67, 1.46) 280,238 65 1.77 (1.08, 2.89)
Q3 92,534 23 1.09 (0.67, 1.77) 365,271 88 1.80 (1.11, 2.91)
Q4 61,201 20 1.32 (0.79, 2.19) 0.29 362,227 92 1.84 (1.13, 2.99) 0.14 0.86
Nickel
Q1 312,521 82 1.00 (Referent) 144,002 27 1.00 (Referent)
Q2 157,280 45 1.21 (0.82, 1.76) 291,010 73 1.27 (0.81, 1.98)
Q3 82,026 18 0.95 (0.56, 1.61) 369,485 89 1.14 (0.73, 1.78)
Q4 62,086 14 0.93 (0.52, 1.65) 0.66 366,645 77 1.00 (0.63, 1.58) 0.33 0.84
aHAP metal levels were obtained from the U.S. EPA (2011). We used updated metal exposure incorporating all years of HAP measurement in our analyses. bAdjusted for age and 
smoking (never, past, current, and pack-years). cBased on linear model through the quartile medians.Palacios et al.
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